CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...